<DOC>
	<DOC>NCT01358695</DOC>
	<brief_summary>The purpose of this study is to provide evidence of the safety, tolerance, and efficacy of ANT-1207 in the treatment of Crow's Feet.</brief_summary>
	<brief_title>Clinical Trial To Evaluate ANT-1207 In Subjects With Crow's Feet</brief_title>
	<detailed_description />
	<mesh_term>Botulinum Toxins, Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>mild to moderate Crow's Feet wrinkles (IGA 23) at rest moderate to severe Crow's Feet (IGA 34) on contraction willingness to refrain from any product affecting skin remodeling female subjects must be not pregnant and nonlactating history of periocular surgery, brow lift or related procedures procedures affecting the lateral canthal region in the prior 12 months application of topical prescription medication to the treatment area female subjects who are pregnant or are nursing a child</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Lateral Canthal Lines</keyword>
	<keyword>Crow's Feet</keyword>
</DOC>